Tengion (TNGN) Prospectus filed to register Shares
This prospectus (filed 4/18/11) relates to the disposition of up to 21.5M shares of common and 10,460,875 warrants, which are held by the selling stockholders (named in the prospectus).
The selling stockholders acquired the common stock and the warrants to purchase common stock in a private placement that closed in 3/11.
The Bottom Line: TNGN is not selling any common stock under this prospectus and will not receive any of the proceeds from the sale of shares by the selling stockholders. TNGN will, however, receive the net proceeds of any warrants exercised for cash. Medtronic (MDT) is listed as the largest shareholder at 17.1% and at second with Health Cap IV LP doubling its ownership in the last offering to 26% from 14.4%.
Related Posts
Categories: NASDAQ: TNGN, Prospectus to register Shares, Stem Cell Research
